Ethylenediamine

Ethylenediamine

SCHEMBL2995717

NCCN.NCCN.[Cl-].[Cl-].[Ni+2]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Ethylenediamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 1/20 0.40
TSHR P16473 4/20 0.36
CA12 O43570 3/20 0.36
CA6 P23280 3/20 0.36
CA7 P43166 3/20 0.36
CA9 Q16790 3/20 0.36
CA14 Q9ULX7 3/20 0.36
CA5B Q9Y2D0 3/20 0.36
ALDH1A1 P00352 3/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA3 P07451 2/20 0.36
CA4 P22748 2/20 0.36
CA5A P35218 2/20 0.36
LMNA P02545 2/20 0.36
BLM P54132 2/20 0.36
DNM1 Q05193 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylenediamine SCHEMBL3006069 1.00 NFKB1 (0.40) NFKB1TSHRCA12CA6CA7
Ethylenediamine SCHEMBL11586569 1.00
Ethylenediamine SCHEMBL3148612 0.94 NFKB1 (0.36) NFKB1TSHRCA12CA6CA7
Ethylenediamine SCHEMBL3145323 0.94 NFKB1 (0.36) NFKB1TSHRCA12CA6CA7
Ethylenediamine SCHEMBL6664381 0.86
Ethylenediamine SCHEMBL2171867 0.86
Ethylenediamine SCHEMBL11585256 0.86
Ethylenediamine SCHEMBL3748789 0.86 NFKB1 (0.40) NFKB1TSHRCA12CA6CA7
Ethylenediamine SCHEMBL5088800 0.86 NFKB1 (0.40) NFKB1TSHRCA12CA6CA7
Ethylenediamine SCHEMBL311124 0.86 NFKB1 (0.40) NFKB1TSHRCA12CA6CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230226807-A1 Polymer Composites and Methods of Making the Same TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2023-07-20 US disclosed
WO-2021226424-A1 POLYMER COMPOSITES AND METHODS OF MAKING THE SAME TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2021-11-11 WO disclosed
EP-3436537-B1 ANAEROBICALLY CURABLE (METH)ACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2021-09-29 EP disclosed
US-11111416-B2 Anaerobically curable (meth)acrylate compositions Henkel IP & Holding GmbH (DE) 2021-09-07 US disclosed
EP-3402855-B1 CURE OF ANAEROBIC COMPOSITIONS Henkel IP & Holding GmbH (DE) 2021-07-14 EP disclosed
US-10414948-B2 Cure of anaerobic compositions Henkel IP & Holding GmbH (DE) 2019-09-17 US disclosed
US-20190031921-A1 ANAEROBICALLY CURABLE (METH)ACRYLATE COMPOSITIONS HENKEL AG & CO. KGAA (DE) 2019-01-31 US disclosed
US-20180320027-A1 CURE OF ANAEROBIC COMPOSITIONS HENKEL AG & CO. KGAA (DE) 2018-11-08 US disclosed
US-9382179-B2 Nickel modified catalyst for the production of hydroxy ether hydrocarbons by vapor phase hydrogenolysis of cyclic acetals and ketals EASTMAN CHEMICAL COMPANY (US) 2016-07-05 US disclosed
US-20150160149-A1 SENSING MATERIAL FOR GAS SENSOR, GAS SENSOR COMPRISING THE SENSING MATERIAL, METHOD OF PREPARING THE SENSING MATERIAL, AND METHOD OF MANUFACTURING THE GAS SENSOR SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-06-11 US disclosed
US-20140303404-A1 NICKEL MODIFIED CATALYST FOR THE PRODUCTION OF HYDROXY ETHER HYDROCARBONS BY VAPOR PHASE HYDROGENOLYSIS OF CYCLIC ACETALS AND KETALS EASTMAN CHEMICAL COMPANY (US) 2014-10-09 US disclosed
US-8785697-B2 Nickel modified catalyst for the production of hydroxy ether hydrocarbons by vapor phase hydrogenolysis of cyclic acetals and ketals EASTMAN CHEMICAL COMPANY (US) 2014-07-22 US disclosed
US-20120330068-A1 NICKEL MODIFIED CATALYST FOR THE PRODUCTION OF HYDROXY ETHER HYDROCARBONS BY VAPOR PHASE HYDROGENOLYSIS OF CYCLIC ACETALS AND KETALS EASTMAN CHEMICAL COMPANY (US) 2012-12-27 US disclosed
US-8293938-B2 Alkylphosphonous acids, salts and esters, methods for the production thereof, and use of the same CLARIANT FINANCE (BVI) LIMITED (VG) 2012-10-23 US disclosed
US-20100190901-A1 Alkylphosphonous Acids, Salts and Esters, Methods for the Production Thereof, and Use of the Same CLARIANT FINANCE (BVI) LIMITED (VG) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120330068-A1 NICKEL MODIFIED CATALYST FOR THE PRODUCTION OF HYDROXY ETHER HYDROCARBONS BY VAPOR PHASE HYDROGENOLYSIS OF CYCLIC ACETALS AND KETALS KAT5, HRH3, KAT8 NFKB1 1348/4885TSHR 4345/4885CA12 955/4885
US-20140303404-A1 NICKEL MODIFIED CATALYST FOR THE PRODUCTION OF HYDROXY ETHER HYDROCARBONS BY VAPOR PHASE HYDROGENOLYSIS OF CYCLIC ACETALS AND KETALS KAT5, HRH3, KAT8 NFKB1 1348/4885TSHR 4345/4885CA12 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.